EPTIS
EPTIS
BAM Logo
List all PT schemes from provider "UK NEQAS for Leucocyte Immunophenotyping"

Search a Proficiency Testing (PT) scheme in the database

Reset

Country
Testing fields
Product groups
Accreditation
Page 1 of 2 (Hits 1 to 20 of 29)
ID
ID
Country
Country
PT provider
PT provider
PT scheme
PT scheme
Last changed
Last changed
146015 United Kingdom UK NEQAS for Leucocyte Immunophenotyping UK NEQAS for Leucocyte Immunophenotyping BCR::ABL1 and AML Translocation Identification BCR::ABL1 and AML Translocation Identification 2024-05-03
PT provider ID (120044)

146032 United Kingdom UK NEQAS for Leucocyte Immunophenotyping UK NEQAS for Leucocyte Immunophenotyping Post-Stem Cell Transplant Chimerism Monitoring Post-Stem Cell Transplant Chimerism Monitoring 2018-08-23
PT provider ID (120044)

146010 United Kingdom UK NEQAS for Leucocyte Immunophenotyping UK NEQAS for Leucocyte Immunophenotyping Paediatric Acute Leukaemia Translocations Paediatric Acute Leukaemia Translocations 2024-05-17
PT provider ID (120044)

146022 United Kingdom UK NEQAS for Leucocyte Immunophenotyping UK NEQAS for Leucocyte Immunophenotyping BCR::ABL1 Major Quantification BCR::ABL1 Major Quantification 2024-05-17
PT provider ID (120044)

146027 United Kingdom UK NEQAS for Leucocyte Immunophenotyping UK NEQAS for Leucocyte Immunophenotyping BRAF p.Val600Glu (V600E) Mutation Status for Hairy Cell Leukaemia BRAF p.Val600Glu (V600E) Mutation Status for Hairy Cell Leukaemia 2018-08-23
PT provider ID (120044)

146052 United Kingdom UK NEQAS for Leucocyte Immunophenotyping UK NEQAS for Leucocyte Immunophenotyping BCR::ABL1 Kinase Domain Variant (Mutation) Status BCR::ABL1 Kinase Domain Variant (Mutation) Status 2024-04-19
PT provider ID (120044)

146042 United Kingdom UK NEQAS for Leucocyte Immunophenotyping UK NEQAS for Leucocyte Immunophenotyping IG/TCR Clonality Status IG/TCR Clonality Status 2024-05-17
PT provider ID (120044)

146037 United Kingdom UK NEQAS for Leucocyte Immunophenotyping UK NEQAS for Leucocyte Immunophenotyping FLT3 Mutation Status FLT3 Mutation Status 2024-05-17
PT provider ID (120044)

146057 United Kingdom UK NEQAS for Leucocyte Immunophenotyping UK NEQAS for Leucocyte Immunophenotyping KIT p.Asp816Val (D816V) Mutation Status for Mast cell disease KIT p.Asp816Val (D816V) Mutation Status for Mast cell disease 2024-04-19
PT provider ID (120044)

146067 United Kingdom UK NEQAS for Leucocyte Immunophenotyping UK NEQAS for Leucocyte Immunophenotyping NPM1 Mutation Status NPM1 Mutation Status 2024-05-14
PT provider ID (120044)

146062 United Kingdom UK NEQAS for Leucocyte Immunophenotyping UK NEQAS for Leucocyte Immunophenotyping BCR::ABL1 Minor Quantification BCR::ABL1 Minor Quantification 2024-04-19
PT provider ID (120044)

287280 United Kingdom UK NEQAS for Leucocyte Immunophenotyping UK NEQAS for Leucocyte Immunophenotyping Measurable Residual Disease for AML by Flow Cytometry (not accredited) [Measurable Residual Disease for AML by Flow Cytoemtry (not accredited)] Measurable Residual Disease for AML by Flow Cytometry (not accredited) [Measurable Residual Disease for AML by Flow Cytoemtry (not accredited)] 2022-02-11
PT provider ID (120044)

287270 United Kingdom UK NEQAS for Leucocyte Immunophenotyping UK NEQAS for Leucocyte Immunophenotyping Measurable Residual Disease for CLL by Flow Cytometry (not accredited) Measurable Residual Disease for CLL by Flow Cytometry (not accredited) 2022-02-11
PT provider ID (120044)

288363 United Kingdom UK NEQAS for Leucocyte Immunophenotyping UK NEQAS for Leucocyte Immunophenotyping Immune Monitoring Alternative Technologies Immune Monitoring Alternative Technologies 2018-08-23
PT provider ID (120044)

495789 United Kingdom UK NEQAS for Leucocyte Immunophenotyping UK NEQAS for Leucocyte Immunophenotyping Measurable Residual Disease for Plasma Cell Myeloma by Flow Cytometry (not accredited) [Measurable Residual Disease for Plasma Cell Myeloma by Flow Cytometry (not accredited)] Measurable Residual Disease for Plasma Cell Myeloma by Flow Cytometry (not accredited) [Measurable Residual Disease for Plasma Cell Myeloma by Flow Cytometry (not accredited)] 2022-02-11
PT provider ID (120044)

495801 United Kingdom UK NEQAS for Leucocyte Immunophenotyping UK NEQAS for Leucocyte Immunophenotyping Cerebrospinal Fluid (CSF) Immunophenotyping Cerebrospinal Fluid (CSF) Immunophenotyping 2018-08-23
PT provider ID (120044)

495795 United Kingdom UK NEQAS for Leucocyte Immunophenotyping UK NEQAS for Leucocyte Immunophenotyping Haematological Malignancy Bone Marrow Aspirate Assessment Haematological Malignancy Bone Marrow Aspirate Assessment 2018-08-23
PT provider ID (120044)

497464 United Kingdom UK NEQAS for Leucocyte Immunophenotyping UK NEQAS for Leucocyte Immunophenotyping Myeloid Gene Panels (Not Accredited) Myeloid Gene Panels (Not Accredited) 2024-04-19
PT provider ID (120044)

941730 United Kingdom UK NEQAS for Leucocyte Immunophenotyping UK NEQAS for Leucocyte Immunophenotyping Myeloproliferative Neoplasms Diagnostic Testing (partially accredited) Myeloproliferative Neoplasms Diagnostic Testing (partially accredited) 2024-05-03
PT provider ID (120044)

941705 United Kingdom UK NEQAS for Leucocyte Immunophenotyping UK NEQAS for Leucocyte Immunophenotyping Measurable Residual Disease for AML by Molecular Methods (not accredited) Measurable Residual Disease for AML by Molecular Methods (not accredited) 2022-10-28
PT provider ID (120044)

Page 1 of 2 (Hits 1 to 20 of 29)
Disclaimer & Privacy Policy
Any questions or problems? Please contact us at eptis@bam.de.
Application version: 1.23-SNAPSHOT.20230502124635-7925ae379a631fc1ececff45d2921c8db38877d5